Repaglinide and cholestasis Patient Reports February 10, 2010

Repaglinide Side Effects Report #5766671-2
Repaglinide side effect was reported by a Physician from SPAIN on May 30, 2008. Female patient, 72 years of age, was diagnosed with type 2 diabetes mellitus, depression , hypertension, cardiac disorder, osteoarthritis  and was treated with Repaglinide. After drug was administered, patient experienced the following side effects: cholestasis. Repaglinide dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, ENALAPRIL MALEATO, ATORVASTATINA, CONDROITINA. Patient was hospitalized. Patient recovered.